336 related articles for article (PubMed ID: 26428390)
1. Structural basis for pore-forming mechanism of staphylococcal α-hemolysin.
Sugawara T; Yamashita D; Kato K; Peng Z; Ueda J; Kaneko J; Kamio Y; Tanaka Y; Yao M
Toxicon; 2015 Dec; 108():226-31. PubMed ID: 26428390
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of transmembrane beta-barrel formation of staphylococcal pore-forming toxins.
Yamashita D; Sugawara T; Takeshita M; Kaneko J; Kamio Y; Tanaka I; Tanaka Y; Yao M
Nat Commun; 2014 Sep; 5():4897. PubMed ID: 25263813
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal amino-latch region of Hlg2 component of staphylococcal bi-component γ-haemolysin is dispensable for prestem release to form β-barrel pores.
Takeda K; Tanaka Y; Kaneko J
J Biochem; 2020 Oct; 168(4):349-354. PubMed ID: 32330256
[TBL] [Abstract][Full Text] [Related]
4. Interactions between residues in staphylococcal alpha-hemolysin revealed by reversion mutagenesis.
Panchal RG; Bayley H
J Biol Chem; 1995 Sep; 270(39):23072-6. PubMed ID: 7559448
[TBL] [Abstract][Full Text] [Related]
5. Role of the amino latch of staphylococcal alpha-hemolysin in pore formation: a co-operative interaction between the N terminus and position 217.
Jayasinghe L; Miles G; Bayley H
J Biol Chem; 2006 Jan; 281(4):2195-204. PubMed ID: 16227199
[TBL] [Abstract][Full Text] [Related]
6. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification.
Walker B; Bayley H
J Biol Chem; 1995 Sep; 270(39):23065-71. PubMed ID: 7559447
[TBL] [Abstract][Full Text] [Related]
7. Preliminary X-ray crystallographic study of staphylococcal α-haemolysin monomer.
Sugawara T; Yamashita D; Tanaka Y; Kaneko J; Kamio Y; Tanaka I; Yao M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Aug; 69(Pt 8):868-70. PubMed ID: 23908030
[TBL] [Abstract][Full Text] [Related]
8. Chimeric mutants of staphylococcal hemolysin, which act as both one-component and two-component hemolysin, created by grafting the stem domain.
Ghanem N; Kanagami N; Matsui T; Takeda K; Kaneko J; Shiraishi Y; Choe CA; Uchikubo-Kamo T; Shirouzu M; Hashimoto T; Ogawa T; Matsuura T; Huang PS; Yokoyama T; Tanaka Y
FEBS J; 2022 Jun; 289(12):3505-3520. PubMed ID: 35030303
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components.
Yamashita K; Kawai Y; Tanaka Y; Hirano N; Kaneko J; Tomita N; Ohta M; Kamio Y; Yao M; Tanaka I
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17314-9. PubMed ID: 21969538
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous oligomerization of a staphylococcal alpha-hemolysin conformationally constrained by removal of residues that form the transmembrane beta-barrel.
Cheley S; Malghani MS; Song L; Hobaugh M; Gouaux JE; Yang J; Bayley H
Protein Eng; 1997 Dec; 10(12):1433-43. PubMed ID: 9543005
[TBL] [Abstract][Full Text] [Related]
11. Intermolecular ionic interactions serve as a possible switch for stem release in the staphylococcal bi-component toxin for β-barrel pore assembly.
Takeda K; Tanaka Y; Abe N; Kaneko J
Toxicon; 2018 Dec; 155():43-48. PubMed ID: 30312693
[TBL] [Abstract][Full Text] [Related]
12. Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus.
Menestrina G; Dalla Serra M; Comai M; Coraiola M; Viero G; Werner S; Colin DA; Monteil H; Prévost G
FEBS Lett; 2003 Sep; 552(1):54-60. PubMed ID: 12972152
[TBL] [Abstract][Full Text] [Related]
13. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore.
Song L; Hobaugh MR; Shustak C; Cheley S; Bayley H; Gouaux JE
Science; 1996 Dec; 274(5294):1859-66. PubMed ID: 8943190
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family.
Menestrina G; Serra MD; Prévost G
Toxicon; 2001 Nov; 39(11):1661-72. PubMed ID: 11595629
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives.
Karginov VA; Nestorovich EM; Schmidtmann F; Robinson TM; Yohannes A; Fahmi NE; Bezrukov SM; Hecht SM
Bioorg Med Chem; 2007 Aug; 15(16):5424-31. PubMed ID: 17572091
[TBL] [Abstract][Full Text] [Related]
16. Surface labeling of key residues during assembly of the transmembrane pore formed by staphylococcal alpha-hemolysin.
Krishnasastry M; Walker B; Braha O; Bayley H
FEBS Lett; 1994 Dec; 356(1):66-71. PubMed ID: 7988723
[TBL] [Abstract][Full Text] [Related]
17. An intermediate in the assembly of a pore-forming protein trapped with a genetically-engineered switch.
Walker B; Braha O; Cheley S; Bayley H
Chem Biol; 1995 Feb; 2(2):99-105. PubMed ID: 9383410
[TBL] [Abstract][Full Text] [Related]
18. Controlling pore assembly of staphylococcal gamma-haemolysin by low temperature and by disulphide bond formation in double-cysteine LukF mutants.
Nguyen VT; Higuchi H; Kamio Y
Mol Microbiol; 2002 Sep; 45(6):1485-98. PubMed ID: 12354220
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes.
Melo MC; Teixeira LR; Pol-Fachin L; Rodrigues CG
FEMS Microbiol Lett; 2016 Jan; 363(1):fnv207. PubMed ID: 26519261
[TBL] [Abstract][Full Text] [Related]
20. Cluster-forming property correlated with hemolytic activity by staphylococcal γ-hemolysin transmembrane pores.
Tomita N; Abe K; Kamio Y; Ohta M
FEBS Lett; 2011 Nov; 585(21):3452-6. PubMed ID: 22001207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
